Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling

FoxO1 Promotes Mitophagy in the Podocytes of Diabetic Male Mice via the PINK1/Parkin Pathway

(2017) Wen Li et al.   ENDOCRINOLOGY

Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts

(2017) Tsung-Ming Lee et al.   FREE RADICAL BIOLOGY AND MEDICINE

SGLT2 Inhibitors and the Diabetic Kidney

(2016) Paola Fioretto et al.   DIABETES CARE

The potential of SGLT2 inhibitors in phase II clinical development for treating type 2 diabetes

(2016) K. Pafili et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Valsartan inhibits amylin-induced podocyte damage

(2016) Fengjuan Huang et al.   MICROVASCULAR RESEARCH

Erratum: Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

(2016) Linda A. Gallo et al.   Scientific Reports

Luseogliflozin and other sodium-glucose cotransporter 2 inhibitors: no enemy but time?

(2015) Kalliopi Pafili et al.   EXPERT OPINION ON PHARMACOTHERAPY

E-cadherin junctions as active mechanical integrators in tissue dynamics

(2015) Thomas Lecuit et al.   NATURE CELL BIOLOGY

Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes

(2014) Greg L. Plosker   DRUGS

The global implications of diabetes and cancer

(2014) Yuankai Shi et al.   LANCET

Epithelial-mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy

(2014) JUNXIA YAO et al.   Molecular Medicine Reports

Mechanisms of Tubulointerstitial Fibrosis

(2010) M. Zeisberg et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Pathologic Classification of Diabetic Nephropathy

(2010) T. W. C. Tervaert et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Renal glucose transporters: novel targets for hyperglycemia management

(2010) Amanda Mather et al.   Nature Reviews Nephrology

TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Therapeutic Intervention in Diabetic Nephropathy

(2009) Claire E. Hills et al.   AMERICAN JOURNAL OF NEPHROLOGY

Advanced Glycation End-Products Induce Tubular CTGF via TGF- -Independent Smad3 Signaling

(2009) A. C.K. Chung et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Suppressor of cytokine signaling-1 reduces high glucose-induced TGF-β1 and fibronectin synthesis in human mesangial cells

(2008) Yonghong Shi et al.   FEBS LETTERS